Int. J. Curr. Res. Med. Sci. (2018). 4(1): 51-80 51 International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Review Article Volume 4, Issue 1 -2018 A Review on tuberculosis in Human Immunodeficiency Virus infection Ochei Kingsley Chinedum 1 , * Obeagu Emmanuel Ifeanyi 2 , Akpan Emmanuel 1 , and Ezeh-Ifeanyi Gloria Ndidiamaka 3 and Ekelozie Ifeoma Stella 4 1 Family Health International (FHI 360) Country Office, Garki - Abuja, Nigeria 2 Diagnostic Laboratory Unit, Department of Health Services, Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. 3 Department of Medical Laboratory Science, Ebonyi State University, Abakaliki, Nigeria. 4 Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nnewi, Anambra State, Nigeria. Abstract TB is the most common opportunistic infection and the leading cause of death among people living with HIV and AIDS. Tuberculosis a disease caused by a microorganism called Mycobacterium tuberculosis. Pulmonary TB is an airborne disease. When people with active pulmonary TB cough, sneeze, speak, sing, or spit, they expel infectious aerosol droplets 0.5 to 5.0 μm in diameter. One third of the world's population is thought to have been infected with M .tuberculosis, with new infections occurring at a rate of about one per second. In 2010, there were an estimated 8.8 million new cases and 1.5 million associated deaths, mostly occurring in developing countries. The 22 high burden countries, as defined by WHO, are those countries that cover 63% of the world’s population and that account for approximately 80% of the estimated number of new TB cases occurring worldwide each year; some of these countries are also among those with the highest incidence rates of TB per capital. One third of the world’s population, two billion people, carries the TB bacteria. More than nine million of these become sick each year with active TB that can be spread to others. Latent TB disease cannot be spread. HIV has been documented as the most important risk factor for TB incidence and death. It has also been documented that TB co‐infection enhances the multiplication of HIV and accelerates the progression of the infection. Because each speeds up the progression of the other, the alliance between TB and HIV has greatest impact in regions of the world where the two infections are on the increase, particularly Africa and the Asia. Tuberculosis (TB)—a contagious bacterial infection that mainly affects the lungs—is a global public health problem. In 2009, 9.4 million people developed TB, and 1.7 million people died from the disease; a quarter of these deaths were in HIV-positive individuals. Keywords: Tuberculosis, HIV, HIV-Tuberculosis DOI: http://dx.doi.org/10.22192/ijcrms.2018.04.01.008